TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancer.

Cell Death Differ · 2026 · PMC13246786 · PMID 41507361

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

1I ), with hazard ratios of 1.344, 1.323, and 1.338, respectively, all achieving highly significant log-rank p -values (<0.0001).

also in 132,142 other papers

showed a trendno p-value reported

At the experimental endpoint, ex vivo BLI analysis of lung tissues showed a trend toward reduced metastatic seeding in TRMT112 KD mice (Fig. 7 G, H).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.